China Medical Technologies Announces Selected Unaudited Preliminary Financial Results for the Fourth Fiscal Quarter and Full Year Ended March 31, 2009
BEIJING, June 19 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced selected unaudited preliminary financial results for t...
China Medical Technologies Receives SFDA Approval for Its Bladder Cancer FISH Probe
BEIJING, April 27 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its Bladd...
China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System
BEIJING, March 25 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company received quality testing certific...
China Medical Technologies Senior Management Purchased Company Shares
BEIJING, March 6 /PRNewswire-Asia/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that each of Mr. Xiaodong Wu, the Company’s Chairman ...
China Medical Technologies Reports Third Fiscal Quarter Financial Results
BEIJING, March 2 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its unaudited financial results for the thi...
China Medical Technologies to Announce Financial Results for the Third Fiscal Quarter Ended December 31, 2008 on March 2, 2009
BEIJING, Feb. 10 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it will report its unaudited financial...
China Medical Technologies Announces the Receipt of SFDA Approval for Two of its FISH Probes and the Approval for the Hi-Tech Enterprise Status for its PRC Subsidiaries
BEIJING, Jan. 22 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval ...
China Medical Technologies Announces the Completion of the Sale of its HIFU Business
BEIJING, Dec. 31 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has completed the previous...
China Medical Technologies Reports Second Fiscal Quarter Financial Results
BEIJING, Dec. 18 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced its full unaudited financial results fo...
China Medical Technologies Announces the Sale of its HIFU Business to a Major Shareholder, Chengxuan International
-- To focus on advanced in-vitro diagnostic businesses which generate recurring revenues -- To strengthen financial position to develop fast growing molecular diagnostic businesses BEIJING, Dec. 18 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CME...
China Medical Technologies Completes the Development of EGFR Molecular Diagnostic Kits
BEIJING, Nov. 20 /PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that it has successfully completed the developme...
China Medical Technologies Announces Selected Unaudited Financial Results for the Second Fiscal Quarter ended September 30, 2008
BEIJING, Nov. 17 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced selected unaudited financial results for...
China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe
- the First SFDA Approved FISH Probe in China BEIJING, Nov. 12 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, toda...
China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
BEIJING, Oct. 29 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced that it will be attending the Credit Sui...
China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
BEIJING, Oct. 27 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products today announced that it will report selected unaudited fin...
China Medical Technologies Acquires HPV-DNA Biosensor Chip and SPR-based Analysis System
-- Broadening Molecular Diagnostic Platforms and Product Offerings -- Strengthening the Company's Leading Position in the Molecular Diagnostic Market in China -- Increasing the Company's High Margin Recurring Revenues -- Expecting Accretion to Adjusted Earnings p...
China Medical Technologies Prices Concurrent Offerings of $240 Million of Convertible Senior Notes and Up To 4,700,000 Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
BEIJING, Aug. 13 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED) today announced the pricing of its public offerings of $240.0 million aggregate principal amount of convertible senior notes due 2013 and up to 4,700,000 American Depositary Shares, ...
China Medical Technologies Announces Concurrent Offerings of $150 Million of Convertible Senior Notes and Purchased ADSs Pursuant to ADS Issuance and Repurchase Agreements
BEIJING, Aug. 12 /Xinhua-PRNewswire/ -- China Medical Technologies, Inc. (the “Company”) (Nasdaq: CMED) today announced that it intends to offer, subject to market and other conditions, $150.0 million aggregate principal amount of convertible senior notes due 2013 and American Depositary Shares,...
China Medical Technologies Reports First Quarter Financial Results
BEIJING, Aug. 4 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy s...
China Medical Technologies Adjusts Conversion Rate of Convertible Notes
BEIJING, July 25 /Xinhua-PRNewswire-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products and high intensity focused ultrasound tumor therapy ...
